Literature DB >> 1389058

Distortion-product otoacoustic emissions. Values for clinical use.

P Bonfils1, P Avan.   

Abstract

Distortion-product otoacoustic emissions are otoacoustic emissions evoked by two pure tones. They are proposed as a frequency-specific test of the mechanical properties of the cochlea. The aim of this study was to measure distortion-product otoacoustic emissions in a clinical setting to establish the most interesting values suitable for clinical use and the clinical interest of the method. The statistical analysis of the data points out some clinically interesting values: (1) a screening limit value of 30 dB hearing level and when measuring distortion-product otoacoustic emissions in response to 52 dB sound pressure level for studying active frequency selective mechanisms; (2) a screening limit value of 50 dB hearing level and when measuring distortion-product otoacoustic emissions in response to 72 dB sound pressure level for studying passive cochlear mechanisms; and (3) the slope of the input-output function. All physiologic properties of the cochlea fit with these basic distortion-product otoacoustic emission properties. These criteria can be used whatever the population studied and the material used for distortion-product otoacoustic emissions recordings. Distortion-product otoacoustic emissions can be used as a screening test to separate (1) subjects with normal hearing and subjects with a hearing threshold above 30 dB hearing level (distortion-product otoacoustic emissions in response to a 52 dB sound pressure level "primaries" [ie, pure tones] stimulation intensity), and (2) patients with a hearing threshold above or below 50 dB hearing level (distortion-product otoacoustic emissions in response to a 72 dB sound pressure level primary stimulation intensity). Distortion-product otoacoustic emissions cannot be used as a more precise audiometric test.

Entities:  

Mesh:

Year:  1992        PMID: 1389058     DOI: 10.1001/archotol.1992.01880100061014

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  7 in total

1.  Limitations in the use of distortion product otoacoustic emissions in objective audiometry as the result of fine structure.

Authors:  J Heitmann; B Waldmann; P K Plinkert
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Multivariate DPOAE metrics for identifying changes in hearing: perspectives from ototoxicity monitoring.

Authors:  Dawn Konrad-Martin; Kelly M Reavis; Garnett P McMillan; Marilyn F Dille
Journal:  Int J Audiol       Date:  2012-02       Impact factor: 2.117

Review 3.  Auditory neuropathy/dys-synchrony and its perceptual consequences.

Authors:  Gary Rance
Journal:  Trends Amplif       Date:  2005

4.  Is obstructive sleep apnea syndrome a risk factor for auditory pathway?

Authors:  Manuele Casale; Emanuela Vesperini; Massimiliano Potena; Marco Pappacena; Federica Bressi; Peter Jarden Baptista; Fabrizio Salvinelli
Journal:  Sleep Breath       Date:  2011-04-09       Impact factor: 2.816

5.  Distortion-product otoacoustic emission input/output characteristics in normal-hearing and hearing-impaired human ears.

Authors:  Stephen T Neely; Tiffany A Johnson; Judy Kopun; Darcia M Dierking; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2009-08       Impact factor: 1.840

Review 6.  The study of otoacoustic emissions and the suppression of otoacoustic emissions in subjects with tinnitus and normal hearing: an insight to tinnitus etiology.

Authors:  Lucieny Serra; Gabriela Novanta; Andre Lopes Sampaio; Carlos Augusto Oliveira; Ronaldo Granjeiro; Silvia Cristina Braga
Journal:  Int Arch Otorhinolaryngol       Date:  2014-06-18

7.  Effects of parenteral papaverine and piracetam administration on cochlea following acoustic trauma.

Authors:  Nurcan Yurtsever Kum; Yavuz F Yilmaz; Seren G Gurgen; Rauf O Kum; Muge Ozcan; Adnan Unal
Journal:  Noise Health       Date:  2018 Mar-Apr       Impact factor: 0.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.